Samanta S, Chakraborty S, Bagchi D. Pathogenesis of Neurodegenerative Diseases and the Protective Role of Natural Bioactive Components. J Am Nutr Assoc. 2024;43:20–32.

CAS  PubMed  Google Scholar 

Liu X, Liu Y, Liu J, Zhang H, Shan C, Guo Y, et al. Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence. Neural Regen Res. 2024;19:833–45.

Article  PubMed  Google Scholar 

Prince M, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M. World Alzheimer report 2015. The global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International; 2015.

Cantón-Habas V, Rich-Ruiz M, Romero-Saldaña M, Carrera-Gonzalez MdP. Depression as a risk factor for dementia and Alzheimer’s disease. Biomedicines. 2020;8:457.

Article  PubMed  PubMed Central  Google Scholar 

Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology. 2013;80:1778–83.

Article  PubMed  PubMed Central  Google Scholar 

Canevelli M, Lacorte E, Cova I, Zaccaria V, Valletta M, Raganato R, et al. Estimating dementia cases amongst migrants living in Europe. Eur J Neurol. 2019;26:1191–9.

Article  CAS  PubMed  Google Scholar 

Marsh DT, Das S, Ridell J, Smid SD. Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2′,3′,4′-trihydroxyflavone (2-D08). Bioorg Med Chem. 2017;25:3827–34.

Article  CAS  PubMed  Google Scholar 

Murphy MP, LeVine H. 3rd, Alzheimer’s disease and the amyloid-beta peptide. J Alzheimers Dis. 2010;19:311–23.

Article  PubMed  PubMed Central  Google Scholar 

Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol. 2018;14:450–64.

Article  CAS  PubMed  Google Scholar 

Nakajima A, Aoyama Y, Shin E-J, Nam Y, Kim H-C, Nagai T, et al. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer’s disease (3XTg-AD). Behav Brain Res. 2015;289:69–77.

Article  CAS  PubMed  Google Scholar 

Qi G, Mi Y, Fan R, Li R, Liu Z, Liu X. Nobiletin protects against systemic inflammation-stimulated memory impairment via MAPK and NF-κB signaling pathways. J Agric Food Chem. 2019;67:5122–34.

Article  CAS  PubMed  Google Scholar 

Cirmi S, Ferlazzo N, Lombardo GE, Ventura-Spagnolo E, Gangemi S, Calapai G, et al. Neurodegenerative diseases: might citrus flavonoids play a protective role? Molecules. 2016;21:1312.

Article  PubMed  PubMed Central  Google Scholar 

Bellavite P. Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action. Antioxidants. 2023;12:280.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taghizadieh M, Modiri N, Salmaninejad A, Khayami R, Taheri F, Moghoofei M, et al. Chapter 6 - Neuroprotective effects of flavonoids. In: Khan H, Aschner M, Mirzaei H, editors, Phytonutrients and Neurological Disorders. Academic Press; 2023, pp. 133–200.

Pang Y, Xiong J, Wu Y, Ding W. A review on recent advances on nobiletin in central and peripheral nervous system diseases. Eur J Med Res. 2023;28:485.

Article  PubMed  PubMed Central  Google Scholar 

Wang H-H, Sun Y-N, Qu T-Q, Sang X-Q, Zhou L-M, Li Y-X, et al. Nobiletin Prevents D-Galactose-Induced C2C12 Cell Aging by Improving Mitochondrial Function. Int J Mol Sci. 2022;23:11963.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang D, Gao F, Hu F, Wu J. Nobiletin Alleviates Astrocyte Activation and Oxidative Stress Induced by Hypoxia In Vitro. Molecules. 2022;27:1962.

Jahan S, Ansari UA, Siddiqui AJ, Iqbal D, Khan J, Banawas S, et al. Nobiletin Ameliorates Cellular Damage and Stress Response and Restores Neuronal Identity Altered by Sodium Arsenate Exposure in Human iPSCs-Derived hNPCs. Pharmaceuticals. 2022;15:593.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Devkota HP, Adhikari-Devkota A, Dirar AI, Belwal T. Chapter 3.1.14 - Nobiletin. In: Belwal T, Nabavi SM, Nabavi SF, Dehpour AR, Shirooie S, editors. Naturally Occurring Chemicals Against Alzheimer’s Disease. Academic Press; 2021. pp. 185–196.

Miyata Y, Nagase T, Katsura Y, Takahashi H, Natsugari H, Oshitari T, et al. In vitro studies on nobiletin isolated from citrus plants and the bioactive metabolites, inhibitory action against gelatinase enzymatic activity and the molecular mechanisms in human retinal Müller cell line,. Biomedicine Pharmacother. 2017;93:70–80.

Article  CAS  Google Scholar 

Kesharwani SS, Mallya P, Kumar VA, Jain V, Sharma S, Dey S. Nobiletin as a molecule for formulation development: an overview of advanced formulation and nanotechnology-based strategies of nobiletin. Aaps Pharmscitech. 2020;21:1–13.

Article  Google Scholar 

Hung W-L, Chiu T-H, Wei G-J, Pan M-H, Ho C-T, Hwang LS, et al. Neuroprotective effects of nobiletin and tangeretin against amyloid β1-42-induced toxicity in cultured primary rat neurons. Nutrire. 2023;48:56.

Article  CAS  Google Scholar 

Ghasemi-Tarie R, Kiasalari Z, Fakour M, Khorasani M, Keshtkar S, Baluchnejadmojarad T, et al. Nobiletin prevents amyloid β1-40-induced cognitive impairment via inhibition of neuroinflammation and oxidative/nitrosative stress. Metab Brain Dis. 2022;37:1337–49.

Article  CAS  PubMed  Google Scholar 

Mileykovskaya E, Yoo S-H, Dowhan W, Chen Z. Nobiletin: targeting the circadian network to promote bioenergetics and healthy aging. Biochemistry. 2020;85:1554–9.

CAS  PubMed  Google Scholar 

Amarsanaa K, Kim H-J, Ko E-A, Jo J, Jung S-C. Nobiletin exhibits neuroprotective effects against mitochondrial complex I inhibition via regulating apoptotic signaling. Exp Neurobiol. 2021;30:73.

Article  PubMed  PubMed Central  Google Scholar 

Li H, Chen G, Ma W, Li P-AA. Water-soluble coenzyme q10 inhibits nuclear translocation of apoptosis inducing factor and cell death caused by mitochondrial complex I inhibition. Int J Mol Sci. 2014;15:13388–13400.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakajima A, Aoyama Y, Nguyen T-TL, Shin E-J, Kim H-C, Yamada S, et al. Nobiletin, a citrus flavonoid, ameliorates cognitive impairment, oxidative burden, and hyperphosphorylation of tau in senescence-accelerated mouse. Behav Brain Res. 2013;250:351–60.

Article  CAS  PubMed  Google Scholar 

Murata T, Ishiwa S, Lin X, Nakazawa Y, Tago K, Funakoshi-Tago M. The citrus flavonoid, nobiletin inhibits neuronal inflammation by preventing the activation of NF-κB,. Neurochem Int. 2023;171:105613.

Article  CAS  PubMed  Google Scholar 

Xiong W, Li R, Li B, Wang X, Wang H, Sun Y, et al. Nobiletin Mitigates D-Galactose-Induced Memory Impairment via Improving Hippocampal Neurogenesis in Mice. Nutrients. 2023;15:2228.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan JZA, Gleeson PA. The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer’s disease. Biochim Biophys Acta. 2019;1861:697–712.

Article  CAS  Google Scholar 

Saha P, Sen N. Tauopathy: A common mechanism for neurodegeneration and brain aging. Mechanisms Ageing Dev. 2019;178:72–79.

Article  CAS  Google Scholar 

Chopra N, Wang R, Maloney B, Nho K, Beck JS, Pourshafie N, et al. MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties. Mol Psychiatry. 2021;26:5636–57.

Article  CAS  PubMed  Google Scholar 

Vaillant-Beuchot L, Mary A, Pardossi-Piquard R, Bourgeois A, Lauritzen I, Eysert F, et al. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains. Acta Neuropathologica. 2021;141:39–65.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future. Signal Transduct Target Ther. 2023;8:248.

Article  CAS